Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

Sabine Vogler; Nina Zimmermann; Zaheer Ud Din Babar; Reinhard Busse; Jaime Espin; Aukje K. Mantel-Teeuwisse; Dimitra Panteli; Fatima Suleman; Veronika J. Wirtz

doi:10.1186/s40545-021-00300-3

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

Sabine Vogler^*, Nina Zimmermann, Zaheer Ud Din Babar, Reinhard Busse, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J. Wirtz

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.

Original language	English
Article number	18
Pages (from-to)	1-5
Journal	Journal of Pharmaceutical Policy and Practice
Volume	14
Issue number	1
DOIs	https://doi.org/10.1186/s40545-021-00300-3
Publication status	Published - 25 Jan 2021

Bibliographical note

Funding Information:
The authors gratefully acknowledge the support of the staff of the WHO Collaborating Centre of Pharmaceutical Pricing and Reimbursement Policies, affiliated to the Pharmacoeconomics Department of Gesundheit ?sterreich GmbH (G?G/Austrian National Public Health Institute). In particular, our sincere thanks go to Stefan Fischer, Manuel Alexander Haasis, Peter Schneider and Friederike Windisch whose notes taken during the conference helped draft this paper.

Publisher Copyright:
© 2021, The Author(s).

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Funding

The authors gratefully acknowledge the support of the staff of the WHO Collaborating Centre of Pharmaceutical Pricing and Reimbursement Policies, affiliated to the Pharmacoeconomics Department of Gesundheit ?sterreich GmbH (G?G/Austrian National Public Health Institute). In particular, our sincere thanks go to Stefan Fischer, Manuel Alexander Haasis, Peter Schneider and Friederike Windisch whose notes taken during the conference helped draft this paper.

Keywords

Access to medicines
Affordability
Collaboration
Debate
Medicine prices
Policy options
Pricing policies
Reimbursement

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s40545-021-00300-3Licence: CC BY

s40545-021-00300-3Final published version, 1.5 MBLicence: CC BY

Cite this

Vogler, S., Zimmermann, N., Babar, Z. U. D., Busse, R., Espin, J., Mantel-Teeuwisse, A. K., Panteli, D., Suleman, F., & Wirtz, V. J. (2021). Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference. Journal of Pharmaceutical Policy and Practice, 14(1), 1-5. Article 18. https://doi.org/10.1186/s40545-021-00300-3

@article{53f03f4092c2470c9628bb1b8454b7f6,

title = "Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference",

abstract = "The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.",

keywords = "Access to medicines, Affordability, Collaboration, Debate, Medicine prices, Policy options, Pricing policies, Reimbursement",

author = "Sabine Vogler and Nina Zimmermann and Babar, {Zaheer Ud Din} and Reinhard Busse and Jaime Espin and Mantel-Teeuwisse, {Aukje K.} and Dimitra Panteli and Fatima Suleman and Wirtz, {Veronika J.}",

note = "Funding Information: The authors gratefully acknowledge the support of the staff of the WHO Collaborating Centre of Pharmaceutical Pricing and Reimbursement Policies, affiliated to the Pharmacoeconomics Department of Gesundheit ?sterreich GmbH (G?G/Austrian National Public Health Institute). In particular, our sincere thanks go to Stefan Fischer, Manuel Alexander Haasis, Peter Schneider and Friederike Windisch whose notes taken during the conference helped draft this paper. Publisher Copyright: {\textcopyright} 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = jan,

day = "25",

doi = "10.1186/s40545-021-00300-3",

language = "English",

volume = "14",

pages = "1--5",

journal = "Journal of Pharmaceutical Policy and Practice",

issn = "2052-3211",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

Vogler, S, Zimmermann, N, Babar, ZUD, Busse, R, Espin, J, Mantel-Teeuwisse, AK, Panteli, D, Suleman, F & Wirtz, VJ 2021, 'Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference', Journal of Pharmaceutical Policy and Practice, vol. 14, no. 1, 18, pp. 1-5. https://doi.org/10.1186/s40545-021-00300-3

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference. / Vogler, Sabine; Zimmermann, Nina; Babar, Zaheer Ud Din et al.
In: Journal of Pharmaceutical Policy and Practice, Vol. 14, No. 1, 18, 25.01.2021, p. 1-5.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Addressing the medicines access challenge through balance, evidence, collaboration and transparency

T2 - key take-away lessons of the 4th PPRI Conference

AU - Vogler, Sabine

AU - Zimmermann, Nina

AU - Babar, Zaheer Ud Din

AU - Busse, Reinhard

AU - Espin, Jaime

AU - Mantel-Teeuwisse, Aukje K.

AU - Panteli, Dimitra

AU - Suleman, Fatima

AU - Wirtz, Veronika J.

N1 - Funding Information: The authors gratefully acknowledge the support of the staff of the WHO Collaborating Centre of Pharmaceutical Pricing and Reimbursement Policies, affiliated to the Pharmacoeconomics Department of Gesundheit ?sterreich GmbH (G?G/Austrian National Public Health Institute). In particular, our sincere thanks go to Stefan Fischer, Manuel Alexander Haasis, Peter Schneider and Friederike Windisch whose notes taken during the conference helped draft this paper. Publisher Copyright: © 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/1/25

Y1 - 2021/1/25

N2 - The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.

AB - The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.

KW - Access to medicines

KW - Affordability

KW - Collaboration

KW - Debate

KW - Medicine prices

KW - Policy options

KW - Pricing policies

KW - Reimbursement

UR - http://www.scopus.com/inward/record.url?scp=85099760662&partnerID=8YFLogxK

U2 - 10.1186/s40545-021-00300-3

DO - 10.1186/s40545-021-00300-3

M3 - Comment/Letter to the editor

C2 - 33494798

AN - SCOPUS:85099760662

SN - 2052-3211

VL - 14

SP - 1

EP - 5

JO - Journal of Pharmaceutical Policy and Practice

JF - Journal of Pharmaceutical Policy and Practice

IS - 1

M1 - 18

ER -

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference

Abstract

Bibliographical note

Funding

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this